ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...
Shares of ResMed (NYSE:RMD) fell 6% today, despite the company reporting second-quarter earnings that surpassed analyst ...
Chicago Partners Investment Group LLC acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the 4th ...
ResMed Inc (ASX: RMD) shares are on the move on Friday after the sleep disorder treatment company delivered a strong Q2 ...
Shares of ResMed Inc. shed 8.33% to $236.18 Friday, on what proved to be an all-around dismal trading session for the ...
ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...
ResMed reported robust earnings for the second quarter of fiscal 2025, surpassing expectations and showcasing strong growth ...
Discover 9 top dividend stocks with 10%+ 5-year return potential based on my valuations and in-depth analysis. Click here.
Jarden Remains a Buy on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
In a report released on February 1, Steven Wheen from Jarden maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 ...
Wilsons analyst Shane Storey downgraded Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research Report) to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results